2 years ago

MAPK pathway activation leads to Bim loss and histone deacetylase inhibitor resistance: rationale to combine romidepsin with an MEK inhibitor

Romidepsin is transformed in cells to its energetic form by the reduction of the disulfide bond by glutathione,